How Much Does Testosterone Cypionate Cost in New Mexico in 2026?

New Mexico Cash-Pay Prices for Testosterone Cypionate

The average cash price for a one-month supply of generic testosterone cypionate at New Mexico retail pharmacies is approximately $60 in 2026. That figure reflects the 200 mg/mL, 1 mL vial, the most commonly prescribed formulation for testosterone replacement therapy (TRT). Prices vary by pharmacy, city, and whether a discount card is applied.

Price Range Across NM Pharmacies

A 10 mL multi-dose vial of testosterone cypionate 200 mg/mL (a roughly 10-week supply at 200 mg per week) costs between $40 and $120 at major chain pharmacies in Albuquerque, Santa Fe, and Las Cruces. Walmart and Costco pharmacies tend to sit at the lower end of that range. Independent pharmacies occasionally charge more due to smaller purchasing volumes.

How List Price Compares to Street Price

The manufacturer list price (sometimes called wholesale acquisition cost) for generic testosterone cypionate runs about $100 per month. Few patients actually pay that number. Pharmacy benefit managers negotiate lower rates, and free discount tools like GoodRx or RxSaver regularly bring the out-of-pocket cost below $50 for a 1 mL vial at select NM locations. The FDA-approved prescribing information for testosterone cypionate confirms the drug has been available in generic form for decades, which keeps pricing competitive.

Vial Size Matters

Choosing a 10 mL vial over a 1 mL vial cuts the per-dose cost significantly. A 10 mL vial might cost $80 to $100 total, while ten individual 1 mL vials would run $400 or more. Ask your prescriber to write the script for the multi-dose vial if cost is a concern.

New Mexico Medicaid and Testosterone Cypionate

New Mexico Medicaid does not cover testosterone cypionate for the diagnosis of male hypogonadism as of 2026. This applies to both Centennial Care 2.0 managed care organizations (Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and Western Sky Community Care).

Why Medicaid Denies Coverage

Medicaid formulary committees in many states classify TRT as a "lifestyle" medication when the primary diagnosis code is male hypogonadism (ICD-10 E29.1). New Mexico follows this pattern. Gender-affirming hormone therapy may follow a different coverage pathway under Centennial Care's behavioral health carve-in, but that is a separate clinical indication with its own prior authorization criteria.

Options if You Rely on Medicaid

Patients on Medicaid who need TRT have a few alternatives. Cash-pay at roughly $60 per month is the most straightforward path. Manufacturer copay programs do not typically apply to Medicaid beneficiaries (federal anti-kickback statute restrictions), but 503A compounding pharmacies and telehealth TRT clinics sometimes offer bundled pricing that competes with or beats retail generics.

Compounded Testosterone Cypionate in New Mexico

Compounded testosterone cypionate is legal in New Mexico through licensed 503A pharmacies. These pharmacies operate under state Board of Pharmacy oversight and must hold a valid compounding license. The average price for a compounded testosterone cypionate vial is about $80 per month.

503A vs. 503B: What New Mexico Allows

Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications based on individual patient prescriptions. New Mexico has no additional state-level ban on compounded testosterone. Section 503B outsourcing facilities can also ship into the state, giving NM patients access to both local and out-of-state compounders.

When Compounding Makes Sense

Compounded testosterone cypionate may be worth considering if you need a non-standard concentration (e.g., 100 mg/mL for lower-volume injections), if you prefer a different carrier oil (grapeseed vs. Cottonseed) due to allergy, or if you want a combined formulation. The T-Trials, a series of seven coordinated placebo-controlled trials (N=790), demonstrated that maintaining serum testosterone in the mid-normal range improved sexual function, physical activity, and mood in men 65 and older with low testosterone 1. Whether using brand, generic, or compounded product, the clinical goal remains the same: consistent physiologic testosterone levels.

Verifying a New Mexico Compounder

Check the New Mexico Board of Pharmacy license lookup tool before filling a compounded prescription. Confirm the pharmacy holds an active compounding permit and has no recent disciplinary actions.

Insurance Coverage for Testosterone Cypionate in NM

Most commercial insurance plans in New Mexico cover generic testosterone cypionate, though the specifics (copay tier, prior authorization requirements, step therapy) vary by carrier and plan design.

Common Carrier Policies

Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, Cigna, and UnitedHealthcare all include generic testosterone cypionate on their formularies, typically at Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Prior authorization usually requires documented low serum testosterone on two morning draws (total testosterone below 300 ng/dL per the Endocrine Society 2018 Clinical Practice Guideline) plus symptoms of hypogonadism.

What Prior Authorization Looks Like

Expect the following documentation requirements from most NM insurers:

• Two fasting morning total testosterone levels below 300 ng/dL, drawn on separate days
• Clinical symptoms (fatigue, decreased libido, erectile dysfunction, reduced lean mass)
• Exclusion of reversible causes (obstructive sleep apnea, opioid use, pituitary pathology)
• Baseline hematocrit below 50%
• PSA and digital rectal exam if age 40 or older

The Endocrine Society guideline recommends against starting TRT in men planning fertility in the near term, men with breast or prostate cancer, hematocrit above 50%, untreated severe sleep apnea, or uncontrolled heart failure 2. Insurers codify these contraindications into their PA criteria.

Copay Expectations

With commercial insurance and a successful prior authorization, the typical copay for a 10 mL vial of generic testosterone cypionate in New Mexico runs $10 to $30. High-deductible health plans may require the full negotiated rate (often $30 to $60) until the deductible is met.

Telehealth TRT in New Mexico

New Mexico permits telehealth prescribing of testosterone cypionate. The state's Telehealth Act (NMSA 24-25-3) allows practitioners to establish a patient-provider relationship via synchronous video visit, and Schedule III controlled substances (which include testosterone) can be prescribed after a telehealth evaluation under the DEA's updated telemedicine rules.

How Telehealth Pricing Works

Telehealth TRT clinics typically charge a monthly or quarterly membership fee ($99 to $199 per month is a common range) that bundles the consultation, lab orders, and sometimes the medication itself. When the medication is bundled, the "cost" of testosterone cypionate is embedded in the subscription. When it is not bundled, the clinic sends a prescription to a retail or compounding pharmacy and the patient pays separately.

Comparing Telehealth to In-Person TRT Costs

A traditional in-person endocrinology visit in Albuquerque might cost $200 to $400 for the initial consult (before insurance). Follow-ups run $100 to $200. Telehealth visits are generally cheaper per encounter, but the subscription model means you pay every month whether you have a visit or not. For a patient on stable TRT who only needs labs and a check-in every 3 to 6 months, the math may favor in-person care with separate pharmacy fills.

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine, found that testosterone replacement in men 45 to 80 years old with hypogonadism and cardiovascular risk did not increase the incidence of major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months 3. This data point matters for telehealth patients who may have been previously denied coverage due to cardiovascular concerns.

Discount Programs and Savings Strategies

Several pathways exist to reduce testosterone cypionate costs in New Mexico beyond standard insurance.

Manufacturer and Third-Party Coupons

Generic testosterone cypionate does not carry a branded manufacturer copay card, but third-party discount platforms (GoodRx, RxSaver, SingleCare, Amazon Pharmacy) negotiate cash-pay rates that frequently beat the pharmacy's default self-pay price. Searching these platforms for Albuquerque, Santa Fe, or Las Cruces zip codes typically returns prices between $25 and $55 for a 1 mL vial.

Patient Assistance Programs

Patients below 200% of the federal poverty level may qualify for assistance through NeedyMeds or RxAssist databases. These programs are more common for brand-name medications, but some compounding pharmacies offer sliding-scale pricing for qualifying patients.

Bulk Purchasing

As noted above, the 10 mL multi-dose vial is the single most effective cost-reduction strategy. A 10 mL vial at $80 provides roughly 10 weeks of medication at a standard 200 mg weekly dose (1 mL per week). That works out to $8 per week, or about $35 per month. This per-unit cost is difficult to beat even with discount coupons applied to 1 mL vials.

90-Day Fills

Some insurance plans and discount programs offer lower per-unit pricing on 90-day supplies. Ask your pharmacy whether a 90-day fill is available for testosterone cypionate. Because it is a Schedule III substance, federal law permits up to a 90-day supply per fill with up to five refills within six months.

Monitoring Costs to Factor In

The price of testosterone cypionate itself is only part of the total cost of TRT. Lab monitoring adds to the annual expense.

Required Labs

The Endocrine Society guideline recommends checking total testosterone, hematocrit, and PSA (in men over 40) at baseline, 3 to 6 months after initiation, and then annually 2. A basic TRT lab panel (total testosterone, free testosterone, estradiol, CBC, CMP, lipid panel, PSA) costs $50 to $150 at direct-to-consumer lab services like Quest or Labcorp when paying out-of-pocket. Insurance-covered labs typically require only a copay.

Supplies

Syringes, needles, and alcohol swabs for self-injection run $5 to $15 per month depending on injection frequency. Most pharmacies in New Mexico sell insulin syringes without a prescription, but larger-gauge IM needles (22 to 25 gauge, 1 to 1.5 inch) may require one.

Annual All-In Cost Estimate

For an uninsured New Mexico patient using generic testosterone cypionate (10 mL vial), self-injecting weekly, and completing two lab panels per year:

• Testosterone cypionate: ~$420 per year (five 10 mL vials)
• Labs (2 panels): ~$150 to $300 per year
• Injection supplies: ~$60 to $120 per year
• Total: roughly $630 to $840 per year

That breaks down to $53 to $70 per month all-in. For comparison, the T-Trials found that the benefits of testosterone on bone mineral density, anemia correction, and sexual function were sustained only while treatment continued 1, making ongoing cost planning important.

New Mexico-Specific Regulatory Notes

Controlled Substance Prescribing

New Mexico requires prescribers to check the Prescription Monitoring Program (PMP) before issuing a Schedule III prescription. Testosterone cypionate falls under this requirement. The check is administrative and does not delay most prescriptions.

Pharmacy Substitution

New Mexico law permits pharmacists to substitute a generic equivalent for a brand-name prescription unless the prescriber writes "DAW" (dispense as written). Since virtually all testosterone cypionate prescriptions are already written for generic, this rarely becomes an issue, but it is worth confirming that your pharmacy is dispensing generic rather than a higher-cost branded product.

Dr. Shalender Bhasin, the principal investigator of the T-Trials, has stated: "Testosterone treatment in older men with low testosterone improved all aspects of sexual function, improved walking distance in the 6-minute walk test, and improved mood and depressive symptoms" 1. These benefits must be weighed against costs and monitoring requirements when making treatment decisions.

The American Urological Association's 2018 guideline adds: "Clinicians should inform testosterone deficient patients that low testosterone is a risk factor for cardiovascular disease" 4, reinforcing the clinical rationale for treatment when a patient meets diagnostic criteria.